NextGen Biomed 2026
Event details
| Date: | March 24, 2026 - March 25, 2026 |
| Website: | https://oxfordglobal.com/nextgen-biomed/ |
| Location: | QEII Centre, London, UK |
NextGen Biomed has evolved over 18 years into a unified platform designed to address the need for interdisciplinary collaboration, year-round engagement and streamlined innovation and best practice sharing. In 2026, four programs will come together, unifying insights from across biologics and immunotherapy R&D.
Browse the programs for this year’s event below.
Gain practical insights from industry pioneers and leading academics on how to design, optimize and manufacture high-performance biologics. Explore next-generation protein and antibody engineering approaches to enhance specificity and stability; hear real-world ADC case studies covering prediction workflows, methods of accelerating development and next-generation design; and discover advanced bioanalytical methods that de-risk development earlier.
Join leaders in peptide and oligonucleotide therapeutics as they share strategies for moving candidates from concept to clinic. Learn how AI-driven design and computational modelling are accelerating discovery, how novel delivery technologies are tackling stability and targeting barriers, and how innovative analytical tools are improving characterisation of complex molecules. Sessions on green chemistry and scalable manufacturing provide practical guidance for reducing costs and environmental impact.
Immunotherapy & immuno-oncology
Hear directly from the senior experts shaping immunotherapy & immuno-oncology. Explore breakthroughs in T cell engagers, cancer vaccines & emerging technologies for cancer & autoimmune diseases. See how biomarker-guided approaches and patient stratification are improving response rates, and learn from translational case studies that bridge lab discoveries with clinical outcomes. Discussions on the tumour microenvironment, utilizing AI/ML technology and regulatory considerations equip you to advance novel immunotherapies with confidence.
Stay ahead of the vaccine landscape with expert perspectives spanning platform innovation through to translational and clinical development. Explore advances in AI/ML-driven vaccine design and preclinical development. Sessions on antigen design, adjuvant selection and immune profiling reveal how developers are creating broader, longer-lasting protection against infectious diseases. Gain valuable lessons from pre-clinical and clinical insights, plus focused discussions into analytics, scale-up and regulatory pathways.
Discover your unmissable moments
Use NextGen Biomed’s new AI tool to instantly generate the sessions, thought leaders and opportunities you cannot afford to miss. Simply enter your company and job title to begin.